Article (Périodiques scientifiques)
Jak1 has a dominant role over Jak3 in signal transduction through γc-containing cytokine receptors
HAAN, Claude; ROLVERING, Catherine; Raulf, F. et al.
2011In Chemistry and Biology, 18 (3), p. 314-323
Peer reviewed
 

Documents


Texte intégral
Haan C-Chem Biol-2011--Jak3 inhib insufficient for IL2 sign inhib.pdf
Postprint Éditeur (1.77 MB)
Demander un accès

Tous les documents dans ORBilu sont protégés par une licence d'utilisation.

Envoyer vers



Détails



Mots-clés :
cytokine receptor; interleukin 2; Janus kinase 1; Janus kinase 3; protein kinase inhibitor; small interfering RNA; STAT5 protein; animal; article; cell line; chemistry; drug antagonism; genetics; human; metabolism; mouse; mutation; phosphorylation; RNA interference; signal transduction; Animals; Cell Line; Humans; Interleukin-2; Janus Kinase 1; Janus Kinase 3; Mice; Mutation; Phosphorylation; Protein Kinase Inhibitors; Receptors; Cytokine; RNA Interference; RNA; Small Interfering; Signal Transduction; STAT5 Transcription Factor
Résumé :
[en] Genetic deficiency of Jak3 leads to abrogation of signal transduction through the common gamma chain (γc) and thus to immunodeficiency suggesting that specific inhibition of Jak3 kinase may result in immunosuppression. Jak1 cooperates with Jak3 in signaling through γc-containing receptors. Unexpectedly, a Jak3-selective inhibitor was less efficient in abolishing STAT5 phosphorylation than pan-Jak inhibitors. We therefore explored the roles of Jak1 and Jak3 kinase functionality in signaling using a reconstituted system. The presence of kinase-inactive Jak1 but not kinase-inactive Jak3 resulted in complete abolishment of STAT5 phosphorylation. Specific inhibition of the "analog-sensitive" mutant AS-Jak1 but not AS-Jak3 by the ATP-competitive analog 1NM-PP1 abrogated IL-2 signaling, corroborating the data with the selective Jak3 inhibitor. Jak1 thus plays a dominant role over Jak3 and these data challenge the notion that selective ATP-competitive Jak3 kinase inhibitors will be effective. © 2011 Elsevier Ltd.
Disciplines :
Biochimie, biophysique & biologie moléculaire
Auteur, co-auteur :
HAAN, Claude ;  University of Luxembourg > Faculty of Science, Technology and Communication (FSTC) > Life Science Research Unit
ROLVERING, Catherine  ;  University of Luxembourg > Faculty of Science, Technology and Communication (FSTC) > Life Science Research Unit
Raulf, F.;  Autoimmunity, Transplantation, and Inflammation, Novartis Institute for Biomedical Research, Basel CH-4056, Switzerland
Kapp, M.;  Autoimmunity, Transplantation, and Inflammation, Novartis Institute for Biomedical Research, Basel CH-4056, Switzerland
Drückes, P.;  Expertise Platform Kinases, Novartis Institute for Biomedical Research, Basel CH-4056, Switzerland
Thoma, G.;  Global Discovery Chemistry, Novartis Institute for Biomedical Research, Basel CH-4056, Switzerland
BEHRMANN, Iris ;  University of Luxembourg > Faculty of Science, Technology and Communication (FSTC) > Life Science Research Unit
Zerwes, H.-G.;  Autoimmunity, Transplantation, and Inflammation, Novartis Institute for Biomedical Research, Basel CH-4056, Switzerland
Langue du document :
Anglais
Titre :
Jak1 has a dominant role over Jak3 in signal transduction through γc-containing cytokine receptors
Date de publication/diffusion :
2011
Titre du périodique :
Chemistry and Biology
ISSN :
1074-5521
Maison d'édition :
Current Biology, London, Royaume-Uni
Volume/Tome :
18
Fascicule/Saison :
3
Pagination :
314-323
Peer reviewed :
Peer reviewed
Commentaire :
cited By (since 1996)18 Scopus
Disponible sur ORBilu :
depuis le 22 avril 2014

Statistiques


Nombre de vues
161 (dont 10 Unilu)
Nombre de téléchargements
1 (dont 1 Unilu)

citations Scopus®
 
183
citations Scopus®
sans auto-citations
180
OpenCitations
 
151
citations OpenAlex
 
201
citations WoS
 
178

Bibliographie


Publications similaires



Contacter ORBilu